|
|
||||||||
Short Communication |




Plum Island Animal Disease Center, USDA-ARS, PO Box 848, Greenport, NY 11944, USA
Correspondence
C. L. Afonso
claudio.afonso{at}ars.usda.gov
| ABSTRACT |
|---|
|
|
|---|
. Lower levels of nitric oxide and increased arginase activity were found in CSFV-infected macrophages. These changes in gene expression in macrophages suggest viral modulation of host expression to suppress nitric oxide production.
Present address: USDA/ARS/SEPRL, 934 College Station Road, Athens, GA 30605, USA. ![]()
Present address: Department of Pathobiology, University of Connecticut, 61 N. Eagleville Road, Storrs, CT 06269, USA. ![]()
Present address: Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, 2522 Vet. Med. Basic Sciences Building, MC-002, 2001 S. Lincoln Avenue, Urbana, IL 61802, USA. ![]()
| MAIN TEXT |
|---|
|
|
|---|
CSFV is an enveloped virus with a single-stranded, 12.5 kb RNA genome of positive polarity (Rice, 1996
). Monocytes and macrophages are the main cell types targeted by CSFV, with infection being non-cytopathic (Knoetig et al., 1999
). Replication of CSFV in macrophages is interferon-sensitive; however, viral infection does not lead to interferon induction. Secretion of prostaglandin E (PGE), a downregulator of immune functions, is increased following infection with CSFV, but lymphocyte proliferation is increased (Knoetig et al., 1999
). These data suggest that CSFV may manipulate the host-cell response directly or indirectly following infection, to permit efficient viral replication.
Macrophages are important in both the initiation and resolution phases of inflammation (Rauh et al., 2005
). Classically activated macrophages, stimulated by gamma interferon (Noel et al., 2004
), eradicate invading micro-organisms through direct killing and releasing of pro-inflammatory cytokines, such as interleukin-1 (IL-1) and cytotoxic products such as nitric oxide (NO) (Noel et al., 2004
; Rauh et al., 2005
). In contrast, alternatively activated macrophages (aaM
), stimulated by cytokines generated by T-helper type 2 (Th2) cells (Noel et al., 2004
), promote only the resolution phase of inflammation via induction of angiogenesis, tissue remodelling, wound healing and type II immunity (Rauh et al., 2005
). aaM
hyporesponsive to pro-inflammatory stimuli resemble tumour-associated macrophages, as well as macrophages from patients with severe and chronic inflammation (Rauh et al., 2005
). These cells fail to generate NO from L-arginine and, therefore, do not limit the growth of intracellular pathogens efficiently (Noel et al., 2004
).
Activity of NO in cellular defence mechanisms includes participation in tissue injury and the mediation of inflammatory processes and apoptosis (Boucher et al., 1999
). NO has also been associated with antiviral activity (Torre et al., 2002
). The antiviral properties of NO, including inhibition of viral RNA synthesis, viral protein accumulation and virus release from infected cells, have been reported previously in both DNA and RNA viruses (Pertile et al., 1996
; Lin et al., 1997
; Xing & Schat, 2000
; Torre et al., 2002
; Akerstrom et al., 2005
; Charnsilpa et al., 2005
). Inhibition of the replication of Japanese encephalitis virus, another member of the family Flaviviridae, was correlated with cellular NO production (Lin et al., 1997
). Arginase-1 has been shown to be upregulated by DNA viruses (Rogers, 1959
; Campadelli-Fiume et al., 1981
; Bonina et al., 1984
). Here, we have used transcriptional profiling of CSFV-infected macrophages to identify cellular genes whose expression is affected by CSFV infection. Data indicate that CSFV inhibits NO production in macrophages and that suppression of NO in infected cells may be significant for CSFV macrophage host range.
Macrophage cell cultures were prepared from swine peripheral blood mononuclear cells as described by Genovesi et al. (1990)
. A cDNA microarray, comprising 7712 sequences obtained from swine macrophages, was manufactured as described previously (Afonso et al., 2004
). CSFV strain Brescia was obtained from the Animal and Plant Health Inspection Service, Plum Island Animal Disease Center, Orient Point, NY, USA, and was propagated and titrated as described previously (Risatti et al., 2005)
. Macrophage cell cultures were mock- or CSFV-infected by using an m.o.i. of 10. At 24 h post-infection (p.i.), RNA was isolated, labelled with either Cy3 or Cy5 monoreactive dye and hybridized to the microarray slides as described previously (Afonso et al., 2004
). In total, eight slides from three independent experiments were analysed; differential expression measurements based on simultaneous two-colour hybridizations were performed with a GenePix 4000A scanner and GenePix Pro 4.0 software (Axon Instruments). Statistical analysis of the GenePix output was performed by using GeneSpring 7.0 software (Agilent Technologies). Data were normalized and analysed as described previously (Afonso et al., 2004
).
Of the host genes examined, approximately 99 % were not affected significantly at 24 h p.i. However, the mRNA levels were increased significantly for 11 genes and reduced significantly for 19 genes (>2.5-fold, P<0.05; Table 1
). Genes showing significantly increased mRNA levels included the enzyme arginase-1, interleukin-1
(IL-1
), chemokine receptor 4 (CCR4), muscleblind-like 1, chemokine ligand 2, phosphoinositide 3-kinase (PI3K), DAX-1 and four genes of unknown function (Table 1
). Genes with significantly reduced expression following CSFV infection were mitochondrial ribosomal protein S25, archain variant 1, angiotensin-converting enzyme, transketolase, osteopontin and 14 other genes of unknown function.
|
was done by using Northern blotting as described previously (Afonso et al., 2004
were 5'-CAGCCATGGCCATAGTACCT-3' and 3'-CCACGATGACAGACACCATC-5'. Comparison with mock-infected controls confirmed the microarray results, demonstrating increased mRNA levels for these genes during infection (Fig. 1a, b
protein expression was confirmed by Western blot as described by Harlow & Lane (1988)
/IL-IF2 (R & D Systems) (Fig. 1d
|
|
The observed reduction in NO, coupled with the increased mRNA levels of arginase-1, PI3K and CCR4 in infected macrophages, resembles a state of macrophage differentiation known as aaM
. aaM
preferentially recruit Th2 cells through interaction with CCR4 (upregulated 2.5-fold in Table 1
) (Noel et al., 2004
), which is a part of the chemokine-receptor system that activates the PI3K pathway (upregulated 2.5-fold in Table 1
) (Cronshaw et al., 2004
). Furthermore, in vivo, differentiated peritoneal and alveolar macrophages that have positive regulation of PI3K have been characterized as aaM
(Rauh et al., 2004
). Whilst classically activated macrophages typically induce functions destined to kill viruses, aaM
promote the resolution phase leading to the downregulation of inflammation.
Increased gene expression of IL-1
is of interest, as it has been shown to induce NO production in a variety of tissues and acts to suppress apoptosis (Chun et al., 1995
; Obermeier et al., 1999
). Whilst the increased transcriptional responses of arginase-1 and IL-1
in CSFV-infected macrophages seem contradictory, the induction of arginase-1 may be a virus-induced response aimed to suppress the effects of IL-1
. Recent work in murine macrophages infected with Streptococcus pyogenes has supported these findings, with genes encoding both IL-1
and arginase-1 being induced in infected cells, whilst iNOS gene expression remained unchanged (Goldmann et al., 2007
). There is also some evidence that the core protein of hepatitis C virus (another member of the family Flaviviridae) may, under certain conditions, inhibit NO production in macrophages or liver tissue (Lee et al., 2001
). Recent data suggest that inverse regulation of iNOS and arginase by a host protein phosphatase is possible and important for virus replication (Bonaparte et al., 2006
); thus, conceivably, CSFV could affect expression of cellular genes to reduce levels of NO.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Akerstrom, S., Mousavi-Jazi, M., Klingstrom, J., Leijon, M., Lundkvist, A. & Mirazimi, A. (2005). Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol 79, 1966–1969.
Bonaparte, K. L., Hudson, C. A., Wu, C. & Massa, P. T. (2006). Inverse regulation of inducible nitric oxide synthase (iNOS) and arginase I by the protein tyrosine phosphatase SHP-1 in CNS glia. Glia 53, 827–835.[CrossRef][Medline]
Bonina, L., Nash, A. A., Arena, A., Leung, K. N. & Wildy, P. (1984). T cell-macrophage interaction in arginase-mediated resistance to herpes simplex virus. Virus Res 1, 501–505.[CrossRef][Medline]
Boucher, J. L., Moali, C. & Tenu, J. P. (1999). Nitric oxide biosynthesis, nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cell Mol Life Sci 55, 1015–1028.[CrossRef][Medline]
Campadelli-Fiume, G., Scannavini, M., Falasca, A., Hakim, G., Busi, C., Mattioli, A. & Fiume, L. (1981). Reduction of simian virus 40 growth by a mitotic inhibitor extracted from liver. Evidence that the inhibitor is arginase. Ann Sclavo 23, 162–168.[Medline]
Chang, C. I., Liao, J. C. & Kuo, L. (1998). Arginase modulates nitric oxide production in activated macrophages. Am J Physiol 274, H342–H348.[Medline]
Charnsilpa, W., Takhampunya, R., Endy, T. P., Mammen, M. P., Jr, Libraty, D. H. & Ubol, S. (2005). Nitric oxide radical suppresses replication of wild-type dengue 2 viruses in vitro. J Med Virol 77, 89–95.[CrossRef][Medline]
Chun, S. Y., Eisenhauer, K. M., Kubo, M. & Hsueh, A. J. (1995). Interleukin-1 beta suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 136, 3120–3127.[Abstract]
Corraliza, I. M., Campo, M. L., Soler, G. & Modolell, M. (1994). Determination of arginase activity in macrophages: a micromethod. J Immunol Methods 174, 231–235.[CrossRef][Medline]
Cronshaw, D. G., Owen, C., Brown, Z. & Ward, S. G. (2004). Activation of phosphoinositide 3-kinases by the CCR4 ligand macrophage-derived chemokine is a dispensable signal for T lymphocyte chemotaxis. J Immunol 172, 7761–7770.
Edwards, S., Moennig, V. & Wensvoort, G. (1991). The development of an international reference panel of monoclonal antibodies for the differentiation of hog cholera virus from other pestiviruses. Vet Microbiol 29, 101–108.[CrossRef][Medline]
Francki, R. I. B., Fauquet, C. M., Knudson, D. L. & Brown, F. (1991). Classification and nomenclature of viruses (fifth report of the International Committee on the Taxonomy of Viruses). Arch Virol Suppl 2, 223–233.
Genovesi, E. V., Villinger, F., Gerstner, D. J., Whyard, T. C. & Knudsen, R. C. (1990). Effect of macrophage-specific colony-stimulating factor (CSF-1) on swine monocyte/macrophage susceptibility to in vitro infection by African swine fever virus. Vet Microbiol 25, 153–176.[CrossRef][Medline]
Gobert, A. P., McGee, D. J., Akhtar, M., Mendz, G. L., Newton, J. C., Cheng, Y., Mobley, H. L. & Wilson, K. T. (2001). Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci U S A 98, 13844–13849.
Goldmann, O., von Kockritz-Blickwede, M., Holtje, C., Chhatwal, G. S., Geffers, R. & Medina, E. (2007). Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect Immun 75, 4148–4157.
Harlow, E. & Lane, D. (1988). Antibodies: a Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
Knoetig, S. M., Summerfield, A., Spagnuolo-Weaver, M. & McCullough, K. C. (1999). Immunopathogenesis of classical swine fever: role of monocytic cells. Immunology 97, 359–366.[CrossRef][Medline]
Lee, C. H., Choi, Y. H., Yang, S. H., Lee, C. W., Ha, S. J. & Sung, Y. C. (2001). Hepatitis C virus core protein inhibits interleukin 12 and nitric oxide production from activated macrophages. Virology 279, 271–279.[CrossRef][Medline]
Lin, Y. L., Huang, Y. L., Ma, S. H., Yeh, C. T., Chiou, S. Y., Chen, L. K. & Liao, C. L. (1997). Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication. J Virol 71, 5227–5235.[Abstract]
Maarsingh, H., Leusink, J., Bos, I. S., Zaagsma, J. & Meurs, H. (2006). Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res 7, 6[CrossRef][Medline]
Nistri, S., Mazzetti, L., Failli, P. & Bani, D. (2002). High-yield method for isolation and culture of endothelial cells from rat coronary blood vessels suitable for analysis of intracellular calcium and nitric oxide biosynthetic pathways. Biol Proced Online 4, 32–37.[CrossRef][Medline]
Noel, W., Raes, G., Hassanzadeh, G. G., De Baetselier, P. & Beschin, A. (2004). Alternatively activated macrophages during parasite infections. Trends Parasitol 20, 126–133.[CrossRef][Medline]
Obermeier, F., Gross, V., Scholmerich, J. & Falk, W. (1999). Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide. J Leukoc Biol 66, 829–836.[Abstract]
Paton, D. J. & Greiser-Wilke, I. (2003). Classical swine fever – an update. Res Vet Sci 75, 169–178.[CrossRef][Medline]
Pertile, T. L., Karaca, K., Sharma, J. M. & Walser, M. M. (1996). An antiviral effect of nitric oxide: inhibition of reovirus replication. Avian Dis 40, 342–348.[CrossRef][Medline]
Rauh, M. J., Sly, L. M., Kalesnikoff, J., Hughes, M. R., Cao, L. P., Lam, V. & Krystal, G. (2004). The role of SHIP1 in macrophage programming and activation. Biochem Soc Trans 32, 785–788.[CrossRef][Medline]
Rauh, M. J., Ho, V., Pereira, C., Sham, A., Sly, L. M., Lam, V., Huxham, L., Minchinton, A. I., Mui, A. & Krystal, G. (2005). SHIP represses the generation of alternatively activated macrophages. Immunity 23, 361–374.[CrossRef][Medline]
Rice, C. M. (1996). Flaviviridae: the viruses and their replication. In Fields Virology, 3rd edn, pp. 931–959. Edited by D. M. Knipe, B. N. Fields & P. M. Howley. Philadelphia, PA: Lippincott–Raven.
Risatti, G. R., Borca, M. V., Kutish, G. F., Lu, Z., Holinka, L. G., French, R. A., Tulman, E. R. & Rock, D. L. (2005). The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine. J Virol 79, 3787–3796.
Rodriguez-Sosa, M., Satoskar, A. R., Calderon, R., Gomez-Garcia, L., Saavedra, R., Bojalil, R. & Terrazas, L. I. (2002). Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability. Infect Immun 70, 3656–3664.
Rogers, S. (1959). Induction of arginase in rabbit epithelium by the Shope rabbit papilloma virus. Nature 183, 1815–1816.[Medline]
Torre, D., Pugliese, A. & Speranza, F. (2002). Role of nitric oxide in HIV-1 infection: friend or foe?. Lancet Infect Dis 2, 273–280.[CrossRef][Medline]
Xing, Z. & Schat, K. A. (2000). Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus. J Virol 74, 3605–3612.
Received 30 March 2007;
accepted 8 July 2007.
This article has been cited by other articles:
![]() |
Z. Shi, J. Sun, H. Guo, and C. Tu Genomic expression profiling of peripheral blood leukocytes of pigs infected with highly virulent classical swine fever virus strain Shimen J. Gen. Virol., July 1, 2009; 90(7): 1670 - 1680. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |